Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...

November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE) approval to initiate the company’s ELITE-BTK pivotal trial of Magnitude, its ...

Merit Medical Systems, Inc. Merit Advance Angiographic Needles 18, 19, 20, 21 (smooth and echo-enhanced) 2.5, 4, 7, 9 Merit Medical Systems, Inc. Merit Advance ...

Sirtex Medical Inc. LAVA Liquid Embolic System: LAVA 18 (2 mL, 6 mL) and LAVA 34 (2 mL, 6mL) EVOH, dimethyl sulfoxide, tantalum Embolization of peripheral arterial hemorrhages An injectable, ...

R3 Vascular Receives IDE Approval for ELITE-BTK Pivotal Trial of Magnitude Scaffold November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE) ...

November 11, 2024—iVascular announced the initiation of OPAL, a first-in-human study of Amber, the company’s embolic liquid ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

LeMaitre Vascular, Inc. Glow 'N Tell 55-cm Tape 55 Centimeter markings on flexible radiopaque ruler LeMaitre Vascular, Inc. Glow 'N Tell Tape 30 Centimeter markings on flexible radiopaque ruler ...

Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

CVRx, Inc. announced recently that the Centers for Medicare and Medicaid Services (CMS) assigned the company’s Barostim p ...

In the LIFE-BTK trial, several initiatives were implemented to facilitate enrollment of diverse populations, ensuring that pati ...